Tenofovir Disoproxil Fumarate
11 NDCs across 11 manufacturers|10 Generic,1 Brand
Tenofovir Disoproxil Fumarate is used to treat acquired immunodeficiency syndrome and chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 26, 2001, and the first generic was approved Mar 18, 2015. FDA's Orange Book lists 23 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $17 million on Tenofovir Disoproxil Fumarate across 84,000 claims for 17,000 beneficiaries.
Tenofovir Disoproxil Fumarate is available as 11 NDCs from 11 manufacturers (10 generic, 1 brand), with NADAC prices from $0.31 to $40.73 per EA — the most expensive product costs about 131× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
10G / 1B
Manufacturers
11
competing in market
Price Spread
$0.31 – $40.73
per EA
7d Activity
avg -1.6% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
11 manufacturers producing TENOFOVIR DISOPROXIL FUMARATE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VIREAD 300 MG TABLET | $40.7283 per EA | 0.00% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET | $0.3110 per EA | -1.70% |
Frequently Asked Questions
What is Tenofovir Disoproxil Fumarate used to treat?
Tenofovir Disoproxil Fumarate is used to treat acquired immunodeficiency syndrome and chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
When did Tenofovir Disoproxil Fumarate become available as a generic?
FDA approved the first generic Tenofovir Disoproxil Fumarate (ANDA) on Mar 18, 2015. The Orange Book currently lists 23 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tenofovir Disoproxil Fumarate?
In 2024, Medicare Part D spent $17 million on Tenofovir Disoproxil Fumarate across 84,000 claims for 17,000 beneficiaries.
How many Tenofovir Disoproxil Fumarate products are on the market?
The Tenofovir Disoproxil Fumarate drug market contains 11 NDCs from 11 manufacturers — 10 generic and 1 brand product.
What is the price range for Tenofovir Disoproxil Fumarate?
NADAC reference prices for Tenofovir Disoproxil Fumarate range from $0.3110 to $40.7283 per EA — the most expensive product costs about 131× the cheapest.
Is generic Tenofovir Disoproxil Fumarate cheaper than brand?
The average generic NADAC for Tenofovir Disoproxil Fumarate is $0.3110 per EA, versus $40.7283 for brand-labeled products — brand versions average about 131× the generic price.
Which manufacturers make Tenofovir Disoproxil Fumarate?
11 manufacturers list Tenofovir Disoproxil Fumarate in NADAC. Ranked by number of NDCs, the largest are Gilead Sciences, Inc. (1), NorthStar Rx LLC (1), Camber Pharmaceuticals Inc. (1), Macleods Pharmaceuticals Limited (1), AvPAK (1).
How has the price of Tenofovir Disoproxil Fumarate changed recently?
Over the past 7 days, 0 Tenofovir Disoproxil Fumarate NDCs rose and 20 fell, with a market-wide average change of -1.6%.